Grantham, Mayo, Van Otterloo & Co (GMO)
PBH icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Prestige Consumer Healthcare PBH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,260
Closed -$261K – 541
2023
Q4 		$261K Sell
4,260
-2,574
-38% -$153K ﹤0.01% 453
2023
Q3 		$391K Sell
6,834
-52,959
-89% -$3.2M ﹤0.01% 511
2023
Q2 		$3.55M Sell
59,793
-10,285
-15% -$615K 0.02% 377
2023
Q1 		$4.39M Sell
70,078
-23,700
-25% -$1.48M 0.02% 336
2022
Q4 		$5.87M Sell
93,778
-23,700
-20% -$1.36M 0.03% 311
2022
Q3 		$5.85M Sell
117,478
-113,700
-49% -$6.3M 0.03% 311
2022
Q2 		$13.6M Buy
231,178
+3,800
+2% +$209K 0.07% 217
2022
Q1 		$12M Sell
227,378
-34,154
-13% -$1.97M 0.06% 232
2021
Q4 		$15.9M Sell
261,532
-1,956
-0.7% -$116K 0.08% 197
2021
Q3 		$14.8M Buy
263,488
+4,400
+2% +$242K 0.07% 206
2021
Q2 		$13.5M Buy
259,088
+13,152
+5% +$632K 0.07% 209
2021
Q1 		$10.8M Buy
245,936
+16,736
+7% +$703K 0.06% 229
2020
Q4 		$7.99M Sell
229,200
-237,400
-51% -$8.43M 0.05% 221
2020
Q3 		$17M Buy
466,600
+27,574
+6% +$1.03M 0.12% 101
2020
Q2 		$16.5M Buy
439,026
+4,526
+1% +$181K 0.12% 99
2020
Q1 		$15.9M Buy
434,500
+125,200
+40% +$4.86M 0.13% 103
2019
Q4 		$12.5M Buy
309,300
+126,500
+69% +$4.72M 0.08% 166
2019
Q3 		$6.34M Buy
182,800
+96,100
+111% +$3.17M 0.04% 262
2019
Q2 		$2.75M Buy
86,700
+48,500
+127% +$1.44M 0.02% 400
2019
Q1 		$1.14M Buy
+38,200
New +$1.09M 0.01% 468

Other funds holding PBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s PBH Position: Q1 2024 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Prestige Consumer Healthcare (PBH) in Q1 2024, closing a stake of 4,260 shares — an estimated $261K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PBH in Q1 2019 and held it in 20 quarters. The position peaked at $17M in Q3 2020. 312 funds tracked by Wall St. Rank hold PBH as of Q1 2024.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Prestige Consumer Healthcare position as of Q1 2024 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,260 Prestige Consumer Healthcare shares in Q1 2024, an estimated $261K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Prestige Consumer Healthcare in Q1 2019 and held it in 20 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Prestige Consumer Healthcare position peaked at $17M in Q3 2020.
  • 312 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2024.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2024, filed 14 May 2024.